logo

RBOT

Vicarious Surgical
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
Signals Analysis
Buy signal 1
Sell signal 0
EPS Beats Expectation

Key Stats

0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000

About RBOT

Vicarious Surgical Inc.

A developer of single-incision surgical robot

Life Science Tools and Services
05/06/2020
09/04/2020
New York Stock Exchange
123
12-31
Common stock
78 Fourth Avenue, Waltham, Massachusetts 02451
--
Vicarious Surgical Inc., a company incorporated in Delaware on May 6, 2020. The company is a next-generation robotics company developing disruptive technologies with the goal of improving surgical efficiency, improving patient outcomes and reducing healthcare costs. The company's new surgical approach uses a combination of proprietary humanoid surgical robots and virtual reality to transport surgeons into patients for minimally invasive surgery. The company's technology received a breakthrough device designation from the FDA, and Vicarious Surgical believes that the Vicarious System is the first surgical robot to receive FDA designation. The company is led by a team of experienced technologists, medical device professionals and physicians and is headquartered in Waltham, Massachusetts.

Earnings Call

Company Financials

EPS

RBOT has released its 2025 Q1 earnings. EPS was reported at -2.58, versus the expected -2.48, missing expectations. The chart below visualizes how RBOT has performed over recent quarters, highlighting trends in earnings surprises.

Forecast

Wall Street Opinions

Price Target

Volume Profile

Trade Flow Insight

Seasonals

Community Forum

Loading...

Related News

No articles available

Related Symbols

You can ask Aime